Published in Immunology on June 29, 2011
Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity (2012) 5.26
Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis (2014) 2.28
Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection. Am J Transplant (2014) 1.49
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation. Proc Natl Acad Sci U S A (2013) 1.38
Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease. Front Immunol (2013) 1.20
T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis. PLoS One (2012) 1.12
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection. Am J Transplant (2016) 1.09
Progesterone and autoimmune disease. Autoimmun Rev (2011) 1.05
Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients. J Transl Med (2013) 1.03
CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals. PLoS One (2014) 0.98
Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. J Virol (2013) 0.95
Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia. Haematologica (2014) 0.92
CD28 Costimulation: From Mechanism to Therapy. Immunity (2016) 0.90
CD28 negative T cells: is their loss our gain? Am J Transplant (2014) 0.90
Inflammation and hypertension: new understandings and potential therapeutic targets. Curr Hypertens Rep (2015) 0.89
Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery Atherosclerosis. Arthritis Rheumatol (2016) 0.88
Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57. Oncotarget (2015) 0.88
CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis. Toxicol Appl Pharmacol (2013) 0.86
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer. Br J Cancer (2013) 0.85
BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties. Oncoimmunology (2015) 0.83
Flt3L combined with rapamycin promotes cardiac allograft tolerance by inducing regulatory dendritic cells and allograft autophagy in mice. PLoS One (2012) 0.83
CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients. J Am Soc Nephrol (2015) 0.82
Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells. Clin Exp Immunol (2013) 0.82
Human mesenchymal stromal cells enhance the immunomodulatory function of CD8(+)CD28(-) regulatory T cells. Cell Mol Immunol (2014) 0.81
Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation. Transplantation (2015) 0.80
Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood (2014) 0.80
Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ. J Immunol (2013) 0.80
Developmentally determined reduction in CD31 during gestation is associated with CD8+ T cell effector differentiation in preterm infants. Clin Immunol (2015) 0.79
CD28⁻ CD8⁺ T cells are significantly reduced and correlate with disease duration in juveniles with type 1 diabetes. Hum Immunol (2014) 0.79
The expression of molecule CD28 and CD38 on CD4⁺/CD8⁺ T lymphocytes in thymus and spleen elicited by Schistosoma japonicum infection in mice model. Parasitol Res (2015) 0.78
CD28 co-stimulation in T-cell homeostasis: a recent perspective. Immunotargets Ther (2015) 0.78
Aging of immune system: Immune signature from peripheral blood lymphocyte subsets in 1068 healthy adults. Aging (Albany NY) (2016) 0.78
Rapid and efficient transfer of the T cell aging marker CD57 from glioblastoma stem cells to CAR T cells. Oncoscience (2015) 0.78
Cytomegalovirus-Productive Infection Is Associated With Acute Coronary Syndrome. J Am Heart Assoc (2016) 0.78
Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome. Clin Exp Immunol (2013) 0.78
Senescent T cells and hypertension: new ideas about old cells. Hypertension (2013) 0.78
Localization of CD8 T cell epitope within cardiac myosin heavy chain-α334-352 that induces autoimmune myocarditis in A/J mice. Int J Cardiol (2015) 0.78
Characterization of the inflammatory cell infiltrate and expression of costimulatory molecules in chronic echinococcus granulosus infection of the human liver. BMC Infect Dis (2015) 0.78
Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients. Med Sci Monit (2015) 0.78
Skin-resident effector memory CD8+CD28- T cells exhibit a pro-fibrotic phenotype in patients with systemic sclerosis. J Invest Dermatol (2016) 0.78
Distribution of Peripheral Lymphocyte Populations in Primary Sjögren's Syndrome Patients. J Immunol Res (2015) 0.77
Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion. Immun Inflamm Dis (2015) 0.77
Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+ T Cells. Arthritis Rheumatol (2016) 0.77
Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer. Oncotarget (2016) 0.76
New insights on the role of CD8(+)CD57(+) T-cells in cancer. Oncoimmunology (2012) 0.76
T cell senescence and cardiovascular diseases. Clin Exp Med (2015) 0.76
CD28-, CD45RA(null/dim) and natural killer-like CD8+ T cells are increased in peripheral blood of women with low-grade cervical lesions. Cancer Cell Int (2014) 0.76
Effects of Heavy Drinking on T-Cell Phenotypes Consistent with Immunosenescence in Untreated HIV Infection. Alcohol Clin Exp Res (2016) 0.76
Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery. Oncoimmunology (2015) 0.76
CD3(+)CD8(+)CD28(-) T Lymphocytes in Patients with Lupus Nephritis. J Immunol Res (2016) 0.75
T cells in multiple myeloma display features of exhaustion and senescence at the tumor site. J Hematol Oncol (2016) 0.75
Evaluating frequency and quality of pathogen-specific T cells. Nat Commun (2016) 0.75
T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies. Front Immunol (2017) 0.75
The spectrum of chronic CD8+ T-cell expansions: clinical features in 14 patients. PLoS One (2014) 0.75
Low perceived social support is associated with CD8+CD57+ lymphocyte expansion and increased TNF-α levels. Biomed Res Int (2014) 0.75
mTOR inhibitors effects on regulatory T cells and on dendritic cells. J Transl Med (2016) 0.75
Immunologic Aging in Adults with Congenital Heart Disease: Does Infant Sternotomy Matter? Pediatr Cardiol (2015) 0.75
Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome. Stem Cell Res Ther (2017) 0.75
Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes. Viruses (2015) 0.75
Reply to Manfredi. J Infect Dis (2014) 0.75
Alteration of T Cell Subtypes in Beta-Thalassaemia Major: Impact of Ferritin Level. J Clin Diagn Res (2016) 0.75
Human lymph-node CD8(+) T cells display an altered phenotype during systemic autoimmunity. Clin Transl Immunology (2016) 0.75
New Murine Model of Early Onset Autoimmune Thyroid Disease/Hypothyroidism and Autoimmune Exocrinopathy of the Salivary Gland. J Immunol (2016) 0.75
Intermittent and graded exercise effects on NK cell degranulation markers LAMP-1/LAMP-2 and CD8(+)CD38(+) in chronic fatigue syndrome/myalgic encephalomyelitis. Physiol Rep (2017) 0.75
Arterial Stiffness Is Associated With Cytomegalovirus-Specific Senescent CD8(+) T Cells. J Am Heart Assoc (2017) 0.75
Distinct aging profiles of CD8+ T cells in blood versus gastrointestinal mucosal compartments. PLoS One (2017) 0.75
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol (2001) 12.26
Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol (2002) 9.45
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol (2007) 7.60
Four faces of cellular senescence. J Cell Biol (2011) 6.86
Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood (2002) 6.73
PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol (2002) 3.78
From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity (2006) 3.56
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis (2011) 3.38
Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol (2003) 3.37
Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol (2002) 3.22
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol (2004) 3.20
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut (2008) 2.97
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78
CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol (2009) 2.66
Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol (2001) 2.45
The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J Leukoc Biol (2008) 2.44
Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians. Immunology (1996) 2.34
Human cell senescence as a DNA damage response. Mech Ageing Dev (2005) 2.26
Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol (1998) 2.18
CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev (2005) 2.16
An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci (2005) 2.15
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res (2005) 2.06
Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin Immunol (2002) 1.97
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res (2007) 1.94
Lessons from the study of T-cell differentiation in persistent human virus infection. Semin Immunol (2004) 1.89
PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS (2007) 1.88
Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol (1999) 1.87
CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol (2009) 1.84
Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J Immunol (2005) 1.82
Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr (2009) 1.78
KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood (2009) 1.73
Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev (2000) 1.68
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol (2004) 1.68
Revisiting immune exhaustion during HIV infection. Curr HIV/AIDS Rep (2011) 1.62
Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. J Virol (2009) 1.62
High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals. J Immunol (2006) 1.55
Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med (2005) 1.53
Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int Immunol (2000) 1.53
Eosinophils in asthma--closing the loop or opening the door? N Engl J Med (2009) 1.49
Dynamics of T cell responses in HIV infection. J Immunol (2002) 1.44
Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol Immunother (2003) 1.40
The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation. Clin Immunol (2000) 1.40
Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin Exp Immunol (1993) 1.38
The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol (2007) 1.38
Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population. Immunology (1999) 1.37
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
CD28 expression in T cell aging and human longevity. Exp Gerontol (1998) 1.36
Predominant involvement of CD8+CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J Virol (1996) 1.35
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol (2007) 1.35
Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol (1989) 1.33
Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol (1999) 1.32
Progressive decrease of CD8high+ CD28+ CD57- cells with ageing. Clin Exp Immunol (1998) 1.28
Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res (2001) 1.26
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol (2006) 1.25
Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Immunology (2001) 1.25
Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress. Exp Gerontol (2010) 1.23
Memory T cells need CD28 costimulation to remember. Semin Immunol (2009) 1.22
CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology (2006) 1.20
CD8+ T suppressor cells are back to the game: are they players in autoimmunity? Autoimmun Rev (2002) 1.18
The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2009) 1.16
Proliferation and interleukin 5 production by CD8hi CD57+ T cells. Eur J Immunol (2008) 1.16
Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines. J Immunol (2006) 1.16
T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol (2009) 1.15
Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood (1994) 1.15
Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death. Neurology (2004) 1.13
Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood (2002) 1.13
License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol (2005) 1.12
A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary response. J Immunol (2004) 1.11
Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer. Clin Exp Immunol (1995) 1.11
Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol (1997) 1.10
Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. Blood (2006) 1.09
The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur J Immunol (2008) 1.09
CD8+CD28- T cells: certainties and uncertainties of a prevalent human T-cell subset. Immunol Cell Biol (2002) 1.09
CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells. Clin Exp Immunol (1994) 1.08
Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. Int Immunopharmacol (2005) 1.07
Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression. Int Immunol (1999) 1.04
Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci (Landmark Ed) (2009) 1.03
Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Exp Hematol (2001) 1.02
Association of Graves' disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. J Clin Immunol (2008) 1.01
CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype. Cancer Immunol Immunother (2005) 1.01
Apoptosis and aging: increased resistance to apoptosis enhances the aging process. Cell Mol Life Sci (2010) 1.01
CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int Immunol (1998) 1.00
Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis. Cell Immunol (2010) 1.00
An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients. Eur J Immunol (1994) 1.00
Microarray analysis reveals similarity between CD8+CD28- T cells from young and elderly persons, but not of CD8+CD28+ T cells. Biogerontology (2008) 1.00
Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response. J Rheumatol (2010) 0.99
Characterization of a cytotoxic CD57+ T cell subset from patients with pulmonary tuberculosis. Clin Immunol (2006) 0.99
Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects. Immunology (2010) 0.97
Apoptosis of CD57+ and CD57- lymphocytes in the lung and blood of HIV-infected subjects. Clin Immunol (2005) 0.96
Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion. Transplantation (2003) 0.95
Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Exp Gerontol (2005) 0.95
Central role of ILT3 in the T suppressor cell cascade. Cell Immunol (2007) 0.94
Alloantigen-induced regulatory CD8+CD103+ T cells. Hum Immunol (2008) 0.94
CD8+ T suppressor cells and the ILT3 master switch. Hum Immunol (2008) 0.94
A subset of CD8 memory T cells from old mice have high levels of CD28 and produce IFN-gamma. Clin Immunol (2002) 0.93
Resurrecting CD8+ suppressor T cells. Nat Immunol (2004) 0.93
CD8high+ (CD57+) T cells in patients with rheumatoid arthritis. Arthritis Rheum (1997) 0.93
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies. Anticancer Res (2013) 1.93
Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinoma. Anticancer Res (2003) 0.91
Peripheral blood CD8highCD57+ lymphocyte levels may predict outcome in melanoma patients treated with adjuvant interferon-alpha. Anticancer Res (2008) 0.88
[Safety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with metastatic breast cancer receiving docetaxel/doxorubicin]. Medicina (Kaunas) (2009) 0.87
CoCanCPG. Coordination of cancer clinical practice in Europe. Tumori (2008) 0.86
"First do no harm" and the importance of prediction in oncology. EPMA J (2010) 0.86
Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2. Anticancer Res (2011) 0.84
Dendritic cells and their role in tumor immunosurveillance. Innate Immun (2012) 0.83
A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample. BMC Cancer (2005) 0.78
Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome? Rheumatol Int (2013) 0.77
Does the "new philosophy" in predictive, preventive and personalised medicine require new ethics? EPMA J (2011) 0.77
The Amiens Strategy: small phase III trials for clinically relevant progress in the war against cancer. J Clin Oncol (2009) 0.76
Expanded effector memory T-lymphocytes in DBA/2 mice do not inhibit the growth of SL2 tumours. In Vivo (2012) 0.75
An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients. Medicina (Kaunas) (2011) 0.75
[Development of research at the Institute of Oncology of Vilnius University]. Medicina (Kaunas) (2004) 0.75